Our study proved a reduction in protein aggregation in the CA1 region of the hippocampus, prefrontal cortex, and nucleus accumbens (NAc) after IGF-1 premedication in a late STZ-induced rat model of AD [36]. Here, IGF1 is linked to Alzheimer disease.